HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgREGISTERwww.epgonline.orgSEARCH
Members
Why a doctor should
Username/Email

Password ()




EPG on Twitter EPG Online Twitter
EPG Online Blog EPG Online Blog
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

ACT-HIB DTP overview
Active immunisation against diphtheria, tetanus, pertussis and invasive diseases caused by Haemophilus influenzae type b.
banner_pass = 1

Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: English
 
 
Related DrugsDrug Details
ACT-HIB DTP
Drug Class Description :

Toxoid vaccines plus inactivated surface antigens (vaccines).

Generic Name :

Haemophilus influenzae type b, diptheria, tetanus, pertussis

Drug description :

Suspension in dual chamber syringe with needle.

Presentation :

Triple antigen adsorbed on aluminium hydroxide, containing diphtheria toxoid not less than 30 i.u., tetanus toxoid not less than 60 i.u., killed B. pertussis not less than 4 i.u. per 0.5 mL. Haemophilus influenzae type b polysaccharide conjugated to tetanus protein equivalent to 10 micrograms of polysaccharide per 0 .5 mL.

Indications :

Active immunisation against diphtheria, tetanus, pertussis and invasive diseases caused by Haemophilus influenzae type b.

Adult Dosage :

Not recommended.

Child Dosage :

Under 2 months, not recommended; two months to four years, three separate injections each of 0 .5 mL by deep subcutaneous or intramuscular injection at minimum of four-week intervals; over four years, not recommended. over four years, not recommended.

Contra Indications :

Acute illness. History of convulsions, cerebral irritation or damage in the neonatal period. Severe local or general reaction to a preceding dose. Neurological disease, developmental neurological defect.

Special Precautions :

History of familial epilepsy.

Adverse Reactions :

Injection site reactions, fever, irritability, persistent crying, loss of appetite, headache, malaise, somnolence, allergic reactions, neurological effects.

Manufacturer :

Aventis Pasteur MSD

Drug Availability :

(POM)

Drug Updated :

01 May 2001

Related Drugs - Vaccines & immunoglobulins
Advancing Immunotherapy in Oncology Male hypogonadism is the term used to describe decreased functional activity of the testes with diminished production and action of testosterone. Cystic Fibrosis Hepatitis
New and updated Drugs
UK Drugs EPG Medical News Feed
Spanish Drugs EPG Medical News Feed
German Drugs EPG Medical News Feed
Norweigan Drugs EPG Medical News Feed
Netherlands Drugs EPG Medical News Feed
Swedish Drugs EPG Medical News Feed
French Drugs EPG French Drugs Feed
Portuguese Drugs EPG Portuguese Drugs Feed
Italian Drugs EPG Italian Drugs Feed

Atopic Dermatitis

Atopic Dermatitis

CONNECT

DISEASE CENTRES Disease Centres feed

AFFILIATE PARTNERS

QUICK SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed

REFERENCES